Annual Total Debt
$43.17 M
+$11.58 M+36.64%
December 31, 2023
Summary
- As of February 7, 2025, RARE annual total debt is $43.17 million, with the most recent change of +$11.58 million (+36.64%) on December 31, 2023.
- During the last 3 years, RARE annual total debt has fallen by -$5.06 million (-10.49%).
- RARE annual total debt is now -10.49% below its all-time high of $48.23 million, reached on December 31, 2020.
Performance
RARE Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$34.08 M
-$3.38 M-9.02%
September 30, 2024
Summary
- As of February 7, 2025, RARE quarterly total debt is $34.08 million, with the most recent change of -$3.38 million (-9.02%) on September 30, 2024.
- Over the past year, RARE quarterly total debt has dropped by -$12.54 million (-26.90%).
- RARE quarterly total debt is now -29.33% below its all-time high of $48.23 million, reached on December 31, 2020.
Performance
RARE Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
RARE Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +36.6% | -26.9% |
| 3 y3 years | -10.5% | -22.6% |
| 5 y5 years | +100.0% | -11.5% |
RARE Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +36.6% | -26.9% | +32.5% |
| 5 y | 5-year | -10.5% | +36.6% | -29.3% | +32.5% |
| alltime | all time | -10.5% | -100.0% | -29.3% | -100.0% |
Ultragenyx Pharmaceutical Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $34.08 M(-9.0%) |
| Jun 2024 | - | $37.46 M(-8.1%) |
| Mar 2024 | - | $40.76 M(-5.6%) |
| Dec 2023 | $43.17 M(+36.6%) | $43.17 M(-7.4%) |
| Sep 2023 | - | $46.62 M(+81.2%) |
| Jun 2023 | - | $25.73 M(-10.0%) |
| Mar 2023 | - | $28.60 M(-9.5%) |
| Dec 2022 | $31.59 M(-24.7%) | $31.59 M(-8.9%) |
| Sep 2022 | - | $34.68 M(-7.6%) |
| Jun 2022 | - | $37.53 M(-4.7%) |
| Mar 2022 | - | $39.37 M(-6.2%) |
| Dec 2021 | $41.97 M(-13.0%) | $41.97 M(-4.7%) |
| Sep 2021 | - | $44.04 M(-4.6%) |
| Jun 2021 | - | $46.17 M(+0.1%) |
| Mar 2021 | - | $46.13 M(-4.3%) |
| Dec 2020 | $48.23 M(+30.4%) | $48.23 M(+8.5%) |
| Sep 2020 | - | $44.45 M(+2.0%) |
| Jun 2020 | - | $43.57 M(+2.6%) |
| Mar 2020 | - | $42.45 M(+14.7%) |
| Dec 2019 | $36.99 M(>+9900.0%) | $36.99 M(-3.9%) |
| Sep 2019 | - | $38.50 M(-3.7%) |
| Jun 2019 | - | $39.97 M(+41.5%) |
| Mar 2019 | - | $28.24 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00 |
| Dec 2011 | $0.00 | - |
FAQ
- What is Ultragenyx Pharmaceutical annual total debt?
- What is the all time high annual total debt for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical annual total debt year-on-year change?
- What is Ultragenyx Pharmaceutical quarterly total debt?
- What is the all time high quarterly total debt for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly total debt year-on-year change?
What is Ultragenyx Pharmaceutical annual total debt?
The current annual total debt of RARE is $43.17 M
What is the all time high annual total debt for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual total debt is $48.23 M
What is Ultragenyx Pharmaceutical annual total debt year-on-year change?
Over the past year, RARE annual total debt has changed by +$11.58 M (+36.64%)
What is Ultragenyx Pharmaceutical quarterly total debt?
The current quarterly total debt of RARE is $34.08 M
What is the all time high quarterly total debt for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly total debt is $48.23 M
What is Ultragenyx Pharmaceutical quarterly total debt year-on-year change?
Over the past year, RARE quarterly total debt has changed by -$12.54 M (-26.90%)